Test Price
2,800 AED✅ Home Collection Available
NR3C2 Gene Hypertension Early Onset Genetic Test in UAE | 2,800 AED | DHA Licensed
Executive Summary & Core Metrics
99.9% Diagnostic Sensitivity via ISO 9001:2015 Certified NGS Processing at DNA Labs UAE. VIP mobile phlebotomy with temperature-controlled cold-chain home collection available daily from 8 AM to 11 PM. Post-test telephonic genetic counselling included. Insurance verification via WhatsApp +971 54 548 8731.
- Test Price: 2,800 AED
- Turnaround Time: 3–4 Weeks
- Methodology: Next-Generation Sequencing (NGS)
- Sample Type: Whole Blood / FTA Card / Extracted DNA
- DHA Facility License: 1143
Test Overview & Methodology
The NR3C2 gene test employs Next-Generation Sequencing to detect pathogenic variants in the mineralocorticoid receptor gene, which are linked to early-onset, salt-sensitive hypertension. This precise molecular analysis enables accurate risk stratification and personalised prevention strategies. At DNA Labs UAE, the test is processed under ISO 9001:2015 certified protocols with rigorous quality control. Each result is accompanied by expert genetic counselling to ensure you and your physician understand the clinical implications and can make informed decisions about lifestyle modifications and medical management.
| Feature | Our NR3C2 NGS Test | Standard Hypertension Panel |
|---|---|---|
| Methodology | Next-Generation Sequencing (NGS) | Limited genotyping or microarray |
| Sensitivity | 99.9% variant detection across entire gene | 70–85% for common variants only |
| Turnaround Time | 3–4 Weeks | 4–6 Weeks |
| Home Collection | VIP Mobile Phlebotomy with ISO Cold-Chain Transport | Not typically available |
Physician Insight & Safety Protocols
Lina Osama Zaki Quteineh | Consultant Medical Genetics | DHA Registration ID: 9294403
"The NR3C2 gene encodes the mineralocorticoid receptor, a central regulator of electrolyte balance and blood pressure. Pathogenic variants in this gene can cause early-onset, salt-sensitive hypertension with significant cardiovascular risk. This NGS-based test provides comprehensive analysis of the entire coding region, enabling early molecular diagnosis and tailored management. However, genetic findings must always be interpreted alongside clinical history, family pedigree, and regular blood pressure monitoring. This test is a complement to—not a replacement for—standard cardiology evaluation."
Medication Advisory
⚠️ Do not discontinue prescribed antihypertensive medication without consulting your doctor.
Genetic test results do not override current clinical therapy. Always discuss any medication changes with your treating physician.
Exclusion Criteria & Emergency Indicators
- Recent blood transfusion or bone marrow transplant (within 4 weeks) may compromise DNA quality—please reschedule.
- This test is not intended for asymptomatic individuals without a family history of early-onset hypertension.
- Seek emergency care immediately if you experience: sudden severe headache, chest pain, vision changes, or a hypertensive crisis (blood pressure >180/120 mmHg).
Patient FAQ & Clinical Guidance
1. What is the NR3C2 gene test and why is it important?
The NR3C2 gene test uses Next-Generation Sequencing to identify mutations in the mineralocorticoid receptor gene that cause early-onset, salt-sensitive hypertension. Early detection enables precise risk assessment and personalised prevention strategies, helping you and your doctor intervene before complications develop. The test screens the entire coding region for pathogenic variants, providing a comprehensive genetic profile.
2. How is the sample collected and what is the turnaround time?
A simple blood draw, FTA card finger-prick, or existing extracted DNA sample is collected at your convenience by our certified phlebotomists using VIP mobile phlebotomy with temperature-controlled cold-chain transport. Home collection is available daily from 8 AM to 11 PM. Results are delivered within 3–4 weeks and include a post-test telephonic session with a genetic counsellor to explain findings and next steps.
3. Will my health insurance cover the NR3C2 genetic test?
Most UAE health insurance plans provide coverage for this test when medically indicated with pre-approval. Our team verifies your eligibility via WhatsApp at +971 54 548 8731 before sample collection. Direct billing can be arranged with major insurers. Please have your policy number ready for a seamless experience.
UAE Regulatory & Data Privacy Adherence
Your data is protected under UAE federal law.
DNA Labs UAE operates in full compliance with Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. All genetic information is encrypted, access-controlled, and used solely for diagnostic purposes with your explicit consent. Clinical safety and patient consent adhere to Federal Decree-Law No. 4 of 2016 on Medical Liability. Your results are confidential and never shared with third parties without your written authorisation.
Clinical & Logistical Metadata
| Test Name | NR3C2 Gene Hypertension Early Onset Genetic Test |
| Price (AED) | 2,800 AED |
| Turnaround Time | 3–4 Weeks |
| Sample Type / Matrix | Whole Blood / FTA Card / Extracted DNA |
| Methodology Used | Next-Generation Sequencing (NGS) |
| ICD-10-CM Code | I10, Z13.79 |
| LOINC Code | 93934-1 |
| DHA Facility License & Laboratory Address | License 1143 | DNA Labs UAE, Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians